Conference scene: molecular pharming: manufacturing medicines in plants.
Immunotherapy
; 5(1): 9-12, 2013 Jan.
Article
em En
| MEDLINE
| ID: mdl-23256793
ABSTRACT
Within the expanding area of molecular pharming, the development of plants for manufacturing immunoglobulins, enzymes, virus-like particles and vaccines has become a major focus point. On 21 September 2012, the meeting 'Molecular Pharming - recent progress in manufacturing medicines in plants', hosted by EuroSciCon, was held at the Bioscience Catalyst campus, Stevenage, UK. The scientific program of this eventful meeting covered diverse highlights of biopharming monoclonal antibodies, virus-like particles from transient and chloroplast expression systems, for example, for Dengue and HPV, apolipoproteins from safflower seeds, and new production platforms, such as potato or hydroponics by rhizosecretion. This report summarizes the stimulating scientific presentations and fruitful panel discussions on the current topics in this promising research field.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Vacinas
/
Plantas Geneticamente Modificadas
/
Agricultura Molecular
/
Anticorpos Monoclonais
Limite:
Humans
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article